Siltussin DM DAS Cough Formula

Product NDC
54838-133
11-digit product format
548380133
Labeler code
54838
Product ID
54838-133_77e74ca8-1539-444b-b810-3115b3a8a154
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin and Dextromethorphan Hydrobromide
Dosage form
LIQUID
Route
ORAL
Labeler
Lannett Company, Inc.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
1995-09-05
Marketing end
2024-03-31
Substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Active strength
10 mg/5mL; mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct54838-133DDiscontinued by firm2026-10-05
excluded packagepackage54838-13354838-133-40DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage54838-133-40d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage54838-133-40f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage54838-133-402ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage54838-133-40a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage54838-133-40cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage54838-133-40cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage54838-133-40302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage54838-133-40ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage54838-133-400efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage54838-133-40ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage54838-133-40367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage54838-133-40557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54838-133-40ML - Milliliter54838-1331ccbda76-d4af-41aa-916e-d5142d5dc36412012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Dextromethorphan HydrobromideACTIVE INGREDIENT9D2RTI9KYHSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
GuaifenesinACTIVE INGREDIENT495W7451VQSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
DextromethorphanACTIVE MOIETY7355X3ROTSSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
GuaifenesinACTIVE MOIETY495W7451VQSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSLSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
glycerinINACTIVE INGREDIENTPDC6A3C0OXSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
mentholINACTIVE INGREDIENTL7T10EIP3ASILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
methylparabenINACTIVE INGREDIENTA2I8C7HI9TSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
propylene glycolINACTIVE INGREDIENT6DC9Q167V3SILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
saccharin sodium dihydrateINACTIVE INGREDIENTSB8ZUX40TYSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
sodium benzoateINACTIVE INGREDIENTOJ245FE5EUSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
sorbitolINACTIVE INGREDIENT506T60A25RSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
waterINACTIVE INGREDIENT059QF0KO0RSILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC]14
DEXTROMETHORPHAN HYDROBROMIDEACTIVE INGREDIENT9D2RTI9KYHGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
GUAIFENESINACTIVE INGREDIENT495W7451VQGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
DEXTROMETHORPHANACTIVE MOIETY7355X3ROTSGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
GUAIFENESINACTIVE MOIETY495W7451VQGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
MENTHOLINACTIVE INGREDIENTL7T10EIP3AGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
SORBITOLINACTIVE INGREDIENT506T60A25RGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1
WATERINACTIVE INGREDIENT059QF0KO0RGUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE LIQUID [LLC FEDERAL SOLUTIONS]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
996520dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral SolutionPSNfc55ad78-97e5-42b7-a6d2-433b5a7bdef32
996520dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral SolutionSCDfc55ad78-97e5-42b7-a6d2-433b5a7bdef32
996520dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral SolutionSYfc55ad78-97e5-42b7-a6d2-433b5a7bdef32
996520dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral SolutionSYfc55ad78-97e5-42b7-a6d2-433b5a7bdef32
996520dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral SolutionSYfc55ad78-97e5-42b7-a6d2-433b5a7bdef32

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
54838-133-4054838013340118 mL in 1 BOTTLE, PLASTIC (54838-133-40) 118 ml1995-09-052024-03-31NoNoCurrent